Lv4
710 积分 2024-03-21 加入
Harnessing the E3 Ligase KLHL12 for Tumor‐Selective Protein Degradation
1个月前
已完结
Insights into SCF ubiquitin ligases from the structure of the Skp1–Skp2 complex
1个月前
已完结
Accelerated Discovery of Carbamate Cbl-b Inhibitors Using Generative AI Models and Structure-Based Drug Design
1个月前
已完结
Molecular basis of the HPV E7-ZER1 axis reveals a ligandable vulnerability in HPV-positive cancers
1个月前
已关闭
Selective CDK6 Degradation via the KLHDC2 E3 Ubiquitin Ligase
2个月前
已完结
BET inhibitors — SPOP right there!
2个月前
已完结
Design and Application of Cereblon-Recruiting Prodegraders
3个月前
已完结
Development of Ligands and Degraders Targeting MAGE-A3
3个月前
已完结
New PROTAC Designs for Targeted Protein Degradation in 2021–2025: Novel E3 Ligases and Pre-PROTACs
3个月前
已完结
Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor Models
4个月前
已完结
皖公网安备34019202002308
